Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Clin Oncol ; 31(20): 2619-26, 2013 Jul 10.
Artículo en Inglés | MEDLINE | ID: mdl-23733769

RESUMEN

PURPOSE: The incidence of pediatric adrenocortical tumors (ACTs) is remarkably high in southern Brazil, where more than 90% of patients carry the germline TP53 mutation R337H. We assessed the impact of early detection of this mutation and of surveillance of carriers. PATIENTS AND METHODS: Free newborn screening was offered at all hospitals in the state of Paraná. Parents of positive newborns were tested, and relatives in the carrier line were offered screening. Positive newborns and their relatives age < 15 years were offered surveillance (periodic clinical, laboratory, and ultrasound evaluations). ACTs detected by imaging were surgically resected. RESULTS: Of 180,000 newborns offered screening, 171,649 were screened, and 461 (0.27%) were carriers. As of April 2012, ACTs had been diagnosed in 11 of these carriers but in only two neonatally screened noncarriers (P < .001); six patient cases were identified among 228 carrier relatives age < 15 years (total, 19 ACTs). Surveillance participants included 347 (49.6%) of 699 carriers. Tumors were smaller in surveillance participants (P < .001) and more advanced in nonparticipants (four with stage III disease; two deaths). Neonatally screened carriers also had neuroblastoma (n = 1), glioblastoma multiforme (n = 1), choroid plexus carcinoma (n = 2), and Burkitt lymphoma (n = 1). Cancer histories and pedigrees were obtained for 353 families that included 1,704 identified carriers. ACTs were the most frequent cancer among carrier children (n = 48). CONCLUSION: These findings establish the prevalence of the TP53 R337H mutation in Paraná state and the penetrance of ACTs among carriers. Importantly, screening and surveillance of heterozygous carriers are effective in detecting ACTs when readily curable.


Asunto(s)
Neoplasias de la Corteza Suprarrenal/epidemiología , Neoplasias de la Corteza Suprarrenal/genética , Predisposición Genética a la Enfermedad/epidemiología , Pruebas Genéticas/métodos , Mutación de Línea Germinal , Proteína p53 Supresora de Tumor/genética , Neoplasias de la Corteza Suprarrenal/diagnóstico , Brasil/epidemiología , Niño , Preescolar , Detección Precoz del Cáncer/métodos , Femenino , Regulación de la Expresión Génica , Heterocigoto , Humanos , Incidencia , Recién Nacido , Masculino , Tamizaje Neonatal/métodos , Linaje , Medición de Riesgo , Distribución por Sexo
2.
Radiol. bras ; 35(3): 183-185, maio-jun. 2002. ilus
Artículo en Portugués | LILACS | ID: lil-322612

RESUMEN

Os autores apresentam o caso de paciente do sexo masculino, 62 anos de idade, com emagrecimento há quatro meses e diminuição da força muscular associada a parestesias em membros inferiores há dois dias. Foi submetido a mielotomografia, que demonstrou massa no mediastino posterior com destruição dos corpos vertebrais e invasão do canal medular, além de espessamento irregular das paredes do esôfago. Na evolução, foi submetido a estudo contrastado do esôfago, que demonstrou falha de enchimento irregular. A biópsia confirmou a presença de carcinoma de células escamosas. Este é o primeiro relato na literatura latino-americana (Lilacs) de carcinoma de esôfago com invasão de canal medular e manifestação inicial de síndrome de compressão medular.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Compresión de la Médula Espinal , Neoplasias de Células Escamosas , Neoplasias Esofágicas/patología , Mielografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA